[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

RU92004433A - Ароматические аминоспиртовые производные, способ их получения и фармацевтическая композиция - Google Patents

Ароматические аминоспиртовые производные, способ их получения и фармацевтическая композиция

Info

Publication number
RU92004433A
RU92004433A RU92004433/04A RU92004433A RU92004433A RU 92004433 A RU92004433 A RU 92004433A RU 92004433/04 A RU92004433/04 A RU 92004433/04A RU 92004433 A RU92004433 A RU 92004433A RU 92004433 A RU92004433 A RU 92004433A
Authority
RU
Russia
Prior art keywords
aminospiral
aromatic
derivatives
production
pharmaceutical composition
Prior art date
Application number
RU92004433/04A
Other languages
English (en)
Other versions
RU2095344C1 (ru
Inventor
Фудзита Такаси
Есиока Такао
Хорикоси Хироеси
Есиока Синдзи
Original Assignee
Санкио Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед filed Critical Санкио Компани Лимитед
Publication of RU92004433A publication Critical patent/RU92004433A/ru
Application granted granted Critical
Publication of RU2095344C1 publication Critical patent/RU2095344C1/ru

Links

Claims (1)

  1. Предложены соединения формулы
    Figure 00000001

    где R0 - водородный атом, метил или гидроксиметил; R1 - замещенный алкил; каждый из R2 и R3 - атом водорода или галогена, гидрокси, алкокси-, карбоксигруппа, алкоксикарбонил, алкил, нитрогруппа, галоидалкил или замещенный алкил; X - атом кислорода или серы; Ar - возможно замещенный фенил или нафтил; их фармацевтически приемлемые соли, обладающие различными ценными фармацевтическими активностями, включая антидиабетическую активность и активность против ожирения. Кроме того, они пригодны для лечения или профилактики гиперлицемии и гипергликемии, а благодаря ингибированию действия альдозоредуктазы они также могут быть эффективными при лечении и профилактике осложнений диабетов.
RU92004433/04A 1991-11-20 1992-11-19 Производные 1-амино-2-замещенного фенилэтанола, способ их получения (варианты) RU2095344C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3-304581 1991-11-20
JP30458191 1991-11-20

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU94036004/04A Division RU2081113C1 (ru) 1991-11-20 1994-09-30 Производное тиазолидин-2,4-диона, способ его получения, производное тиазолидин-2,4-диона в качестве промежуточного продукта при получении ароматических аминоспиртовых производных

Publications (2)

Publication Number Publication Date
RU92004433A true RU92004433A (ru) 1996-04-27
RU2095344C1 RU2095344C1 (ru) 1997-11-10

Family

ID=17934718

Family Applications (2)

Application Number Title Priority Date Filing Date
RU92004433/04A RU2095344C1 (ru) 1991-11-20 1992-11-19 Производные 1-амино-2-замещенного фенилэтанола, способ их получения (варианты)
RU94036004/04A RU2081113C1 (ru) 1991-11-20 1994-09-30 Производное тиазолидин-2,4-диона, способ его получения, производное тиазолидин-2,4-диона в качестве промежуточного продукта при получении ароматических аминоспиртовых производных

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU94036004/04A RU2081113C1 (ru) 1991-11-20 1994-09-30 Производное тиазолидин-2,4-диона, способ его получения, производное тиазолидин-2,4-диона в качестве промежуточного продукта при получении ароматических аминоспиртовых производных

Country Status (23)

Country Link
US (3) US5977374A (ru)
EP (1) EP0543662B1 (ru)
JP (2) JP2654323B2 (ru)
KR (1) KR0149679B1 (ru)
CN (3) CN1034497C (ru)
AT (1) ATE143002T1 (ru)
AU (2) AU655689B2 (ru)
CA (1) CA2083323A1 (ru)
CZ (2) CZ280328B6 (ru)
DE (1) DE69213892T2 (ru)
DK (1) DK0543662T3 (ru)
ES (1) ES2094308T3 (ru)
FI (1) FI925255A (ru)
GR (1) GR3021245T3 (ru)
HK (1) HK218496A (ru)
HU (1) HUT66816A (ru)
IL (3) IL103825A (ru)
MX (1) MX9206740A (ru)
NO (1) NO179246C (ru)
NZ (1) NZ245188A (ru)
RU (2) RU2095344C1 (ru)
TW (2) TW290543B (ru)
ZA (1) ZA928960B (ru)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
GB9313574D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Medicaments
CA2145257A1 (en) * 1994-03-23 1995-09-24 Takashi Fujita Thiazolidine and oxazolidine derivatives, their preparation and their medical use
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
WO1995033724A1 (en) * 1994-06-09 1995-12-14 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525121D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
DE69625795T2 (de) * 1996-04-09 2003-08-14 Dr. Reddy's Laboratories Ltd., Hyderabad Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) * 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5990169A (en) * 1996-10-23 1999-11-23 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
GB9706707D0 (en) * 1997-04-02 1997-05-21 Glaxo Group Ltd Chemical compounds
JPH10338679A (ja) * 1997-04-08 1998-12-22 Mitsubishi Rayon Co Ltd チアゾリジン誘導体の製造方法
GB9812709D0 (en) 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6006419A (en) * 1998-09-01 1999-12-28 Millitech Corporation Synthetic resin transreflector and method of making same
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
GB9929297D0 (en) * 1999-12-11 2000-02-02 Glaxo Group Ltd Process
AU2001241168B2 (en) * 2000-03-17 2005-06-16 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
MXPA03000397A (es) * 2000-07-13 2003-05-27 Sankyo Co Derivados de aminoalcohol.
AP2001002307A0 (en) * 2000-10-20 2001-12-31 Pfizer Prod Inc B3 adrenergic receptor agonists and uses thereof.
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
EP1383729A4 (en) * 2001-04-05 2006-04-19 Smithkline Beecham Corp DEFORMYLASE PEPTIDE INHIBITORS
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
WO2003010157A1 (en) * 2001-07-23 2003-02-06 Dr. Reddy's Research Foundation Dioxane derivatives and a process for their preparation
WO2003016265A1 (fr) 2001-08-17 2003-02-27 Eisai Co., Ltd. Compose cyclique et agoniste du recepteur ppar
AU2003248352A1 (en) 2002-02-27 2003-09-09 Pfizer Products Inc. PROCESSES AND INTERMEDIATES USEFUL IN PREPARING Beta3-ADRENERGIC RECEPTOR AGONISTS
DOP2003000587A (es) * 2002-02-27 2003-08-30 Pfizer Prod Inc AGONISTAS DEL RECEPTOR ß3-ADRENERGICO
AU2003209527A1 (en) 2002-02-27 2003-09-09 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
KR101071748B1 (ko) 2003-12-23 2011-10-11 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
KR20100084604A (ko) 2007-10-24 2010-07-27 쮸 시아오잉 감아올림 스크린 장치
WO2009055869A1 (en) * 2007-11-01 2009-05-07 Howard Florey Institute Aryloxy amine compounds and their use as sodium channel modulators
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
AU2015358378A1 (en) 2014-12-03 2017-06-29 Velicept Therapeutics, Inc. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
US9968531B2 (en) 2015-08-05 2018-05-15 Dupont Tate & Lyle Bio Products Company, Llc Deodorants containing 1,3-propanediol
ES2967863T3 (es) 2015-10-23 2024-05-06 B3Ar Therapeutics Inc Ion dipolar de solabegron y usos del mismo
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
TWI717712B (zh) * 2018-03-26 2021-02-01 南韓商普洛科技股份有限公司 新穎化合物及包含其之用於預防或治療肥胖或代謝症候群的藥學組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3976783A (en) * 1970-07-18 1976-08-24 Pfizer Inc. Method of stimulating the heart employing ureido substituted phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives
GB1551260A (en) * 1976-02-09 1979-08-30 Allen & Hanburys Ltd Phenylethanolamine derivatives
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
GB8620951D0 (en) * 1986-08-29 1986-10-08 Beecham Group Plc Compounds
US5194443A (en) * 1987-09-04 1993-03-16 Beecham Group P.L.C. Compounds
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
US5037842A (en) * 1990-06-05 1991-08-06 Pfizer Inc. Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
HUT70421A (en) * 1991-07-30 1995-10-30 Yamanouchi Pharma Co Ltd Novel bisoxazolidine derivatives pharmaceutical compositions containing them and process for preparing them
GB9313574D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Medicaments

Similar Documents

Publication Publication Date Title
RU92004433A (ru) Ароматические аминоспиртовые производные, способ их получения и фармацевтическая композиция
NO179246C (no) Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
JP2006501181A5 (ru)
KR870006016A (ko) N-벤조일 우레아 화합물, 이를 함유하는 항종양 조성물 및 그의 제조 방법
KR940000447A (ko) 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물
CA2507545A1 (en) Use of furfural derivatives as anti-sickling agents
PT69823A (de) 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saureadditionssalze diese enthaltene arzneimittel und verfahrenzu deren herstellung
BR1100636A (pt) Agente terapêutico para o mal de parkinson, e, derivado da xantina
BR8202861A (pt) Composto composicao farmaceutica processo para baixar a pressao sanguinea de seres humanos processo para preparar um composto e process para preparar uma composicao farmaceutica
KR880000413A (ko) 항알레르기 및 소염 제제와 그의 제조방법
KR927003537A (ko) 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도
RU97103535A (ru) Имидазопиридины азолидиноны
DK0446921T3 (da) Optisk aktive alkylendioxybenzenderivater og deres anvendelse ved terapi
KR960702456A (ko) 4-(p-플로오로페닐)-3-[(3,4-(메틸렌디옥시)페녹시)메틸]피페리딘의 n-p-할로벤조일메틸 유도체(n-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]piperidine)
ES500810A0 (es) Procedimiento de preparacion de aminoalcoxipirazoles
ZA905650B (en) Method of treating diabetes mellitus
ATE76067T1 (de) Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung.
RU93033697A (ru) Производные 2-амино-n-[[[4-(аминокарбонил) пиримидин-2-ил]амино] алкил] пиримидин-4-карбоксамида, способ их получения и фармацевтическая композиция на их основе
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
EP0351696A3 (de) Allylaminoethylazole
ATE64383T1 (de) 8-phenylthiotetrahydrochinolin-derivate und ihre salze, ihre herstellung, verwendung als arzneimittel und zusammensetzungen davon.
DE69011174D1 (de) Catecholaminester.
RU92016596A (ru) Производные пиримидила, способ их получения, нематоцидная композиция и способ борьбы с нематодами
RU92016468A (ru) Новые производные пиримидина, способ их получения, нематоцидная композиция и способ добавления нематод